Revel Pharmaceuticals
CA - San FranciscoPharmaceutical
Focus: Revel Pharmaceuticals is a newly founded (2024) therapeutic enzyme company focused on neurology based in San Francisco. As a pre-revenue biotech, the company is in early-stage development with minimal public pipeline disclosure.
Profile data last refreshed 50m ago · AI intelligence enriched 1w ago
Open Jobs
1
Should You Work at Revel Pharmaceuticals?
AI assessmentRevel is a high-risk, high-reward early-stage bet suitable only for risk-tolerant professionals seeking seed-stage equity upside with tolerance for potential failure.
Why Work Here
- Ground-floor opportunity at a newly founded company with focus on high-value therapeutic enzyme modality in neurology
- San Francisco location offers access to top-tier biotech talent and venture networks
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Revel Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.